Efeitos do carvedilol (Bloqueador beta 1, Beta 2, alfa), na insuficiência cardíaca refratária

Bocchi, Edimir Alcides; Bacal, Fernando; Bellotti, Giovanni; Carrara, Dirceu; Ramires, José Antonio Franchini.
Arq. bras. cardiol ; 71(2): 169-73, ago. 1998. graf
Artículo en Portugués | LILACS | ID: lil-241756

Documentos relacionados

  1. Mechanism and application of ß-adrenoceptor blockers in soft tissue wound healing.
  2. Beta-blocker efficacy across different cardiovascular indications: an umbrella review and meta-analytic assessment.
  3. Enantiocomplementary synthesis of ß-adrenergic blocker precursors via biocatalytic nitration of phenyl glycidyl ethers.
  4. A tale of pigs, beta-blockers and genetic variants.
  5. Evaluation of advanced oxidation processes for ß-blockers degradation: a review.
  6. Prospective benchmarking of an observational analysis in the SWEDEHEART registry against the REDUCE-AMI randomized trial.
  7. Routine Beta-Blockers in Secondary Prevention - On Injured Reserve.
  8. Stereochemical facets of clinical ß-blockers: An overview.
  9. Are beta-blockers safe and effective after myocardial infarction in patients with COPD?
  10. Non-selective beta-blockers increase overall and liver mortality in alcoholic cirrhosis with MELD ≥ 12 over 5 years of follow-up.